• Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $40.00 at Oppenheimer

    المصدر: Buzz FX / 13 يناير 2025 11:46:16   America/New_York


    Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $40.00 at Oppenheimer Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective decreas
    Read more...
شارك على،